Abionyx : A new generation biotech company - Seasoned Scientific Experts and Strategic Pharmaceutical Industry Veterans Join Cerenis’ Scientific Advisory Board in Oncology

EN
FR

Home
About
- About
- Abionyx
- Management
- Board of Directors
- Specialized Committees
  
  - Audit Committee
  - Remuneration Committee
- Scientific Advisory Board
Our Assets
- Our Assets
- CER 001
- CER 002
- CER 209
Indications
Media
- Media
- Press releases
- ABIONYX in the media
Investors

Fichier: pr_cerenis_05022018_SAB.pdf